Fortrea
FTRE | NASDAQ
$19.79
-$0.41 (-2.03%)
At close: Nov 16, 2026, 4:00 PM ET
$19.79
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
Fortrea Company Profile
Company profile explainedCompany Profile
Fortrea Holdings Inc. functions as a global contract research organization (CRO), concentrating on providing development services for biopharmaceutical products and medical devices. The company's operations are divided into two main segments: Clinical Services and Enabling Services. Its Clinical Services division offers support across the entire spectrum of clinical pharmacology and development. The Enabling Services segment, conversely, delivers patient access programs and cutting-edge clinical trial technology solutions, aiming to simplify complex randomization processes and optimize the supply of trial medications for its customers. Fortrea presents a range of engagement options, such as full-service provision, functional service provider (FSP) models, and hybrid structures. Additionally, its portfolio includes managing clinical trials from Phase I through IV, offering distinctive technology-powered trial solutions, and providing post-market approval services. The company's client base primarily consists of pharmaceutical, biotechnology, and medical device entities. Fortrea Holdings Inc. was founded in 2023 and has its headquarters in Durham, North Carolina.
Key Executives
| Name | Position |
|---|---|
| Anshul Thakral | Chief Executive Officer & Director |
| Alejandro Martinez Galindo | Chief Information Officer |
| Jason F. Knoblauch | Chief Financial Officer |
| Mark A. Morais | Chief Operating Officer & President of Clinical Services |
| Agnieszka Gallagher | General Counsel & Corporate Secretary |
| Carrie Russell | VP of Accounting & Chief Accounting Officer |
| Dave Cooper | Chief Administrative Officer |
| David Ross Smith | Interim CFO, Principal Financial Officer & Independent Director |
| Drayton Virkler | President & Chief Commercial Officer |
| Hima Inguva | Head of Corporate Development |
| Jill McConnell | Executive Officer |
| Leonard Scott Dove | President of Clinical Pharmacology Services |
| Oren J. Cohen | Chief Medical Officer |
| Sandy Kennedy | Chief Quality, Regulatory Affairs & Sustainability Officer |
| Tracy H. Krumme | Senior Vice President of Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 29, 2026 | 10-Q | Quarterly Report |
| Oct 29, 2026 | 8-K | Current Report |
| Sep 30, 2026 | 8-K | Current Report |
| Sep 14, 2026 | 4 | Filing |
| Sep 10, 2026 | 4 | Filing |
| Sep 10, 2026 | 4 | Filing |
| Sep 10, 2026 | 8-K | Current Report |
| Aug 19, 2026 | 4 | Filing |
| Aug 17, 2026 | 3 | Filing |
| Aug 07, 2026 | 4 | Filing |
Fortrea
| Country | United States |
| IPO Date | Jun 20, 2023 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 14,000 |
| CEO | Anshul Thakral |
Contact Details
8 Moore Drive Durham,
North Carolina 27713 United States
Stock Details
| Ticker Symbol | FTRE |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001965040 |
| CUSIP Number | 34965K107 |
| ISIN Number | US34965K1079 |
| SIC Code | 8071 |
Recent News
- 3 days ago / seekingalpha.comFortrea: A Promising Turnaround At An Attractive Valuation
- 19 days ago / marketbeat.comWhat Fortrea (FTRE) Said on Its Q3 Earnings Call
- 19 days ago / seekingalpha.comFortrea Holdings Inc. (FTRE) Q3 2026 Earnings Call Transcript
- 19 days ago / zacks.comFortrea Holdings Inc. (FTRE) Q3 Earnings and Revenues Surpass Estimates
- 19 days ago / globenewswire.comFortrea Reports Third Quarter 2026 Results
- 21 days ago / globenewswire.comFortrea to Participate in Jefferies Global Healthcare Conference
- 25 days ago / globenewswire.comFortrea and Omico Collaboration to Advance Biomarker-led Oncology Drug Development
- 26 days ago / zacks.comFortrea Holdings Inc. (FTRE) Earnings Expected to Grow: Should You Buy?
- 28 days ago / globenewswire.comFortrea Completes Acquisition of the Early Phase Services Division from Worldwide Clinical Trials
- 1 month ago / seekingalpha.com3 Top Small-Cap Stocks With Market-Beating Momentum
Add to Watchlist
Select watchlists to add or remove FTRE